Waveguide Corp announced it raised $2.62 Million in an initial filing from an offering of $5 Million

Company

Location

About

WaveGuide Corporation develops medical and industrial diagnostic devices built upon a breakthrough handheld nuclear magnetic resonance (NMR) platform. Qualitative and quantitative in-situ analysis spanning applications from biological samples, BioPharma, Food, Oils & Lubricants, THC/Cannabis through medical diagnostics (tuberculosis and ovarian cancer are 513(g) predicate device approved by the US FDA). Time domain NMR measures the time required for nuclei to return to equilibrium after excitation. It is widely recognized as a reliable, convenient, rapid analytical methodology that shows high reproducibility without the need for sample preparation and is non-destructive.